GOLDMAN SACHS GROUP INC - ADMA BIOLOGICS INC ownership

ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 115 filers reported holding ADMA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ADMA BIOLOGICS INC
ValueSharesWeighting
Q3 2023$8,046,480
+103.2%
2,247,620
+109.4%
0.00%
+100.0%
Q2 2023$3,960,581
+25.6%
1,073,328
+12.7%
0.00%0.0%
Q1 2023$3,152,368
-7.1%
952,377
+8.9%
0.00%0.0%
Q4 2022$3,393,021
+125.2%
874,490
+41.0%
0.00%
Q3 2022$1,507,000
+71.1%
620,210
+39.4%
0.00%
Q2 2022$881,000
-28.1%
444,802
-33.6%
0.00%
Q1 2022$1,226,000
+457.3%
670,222
+329.0%
0.00%
Q4 2021$220,000
-18.5%
156,223
-34.5%
0.00%
Q3 2021$270,000
+17.9%
238,345
+66.9%
0.00%
Q2 2021$229,000
-65.4%
142,805
-62.0%
0.00%
Q1 2021$661,000
+26.1%
375,396
+39.7%
0.00%
Q4 2020$524,000
-63.2%
268,673
-54.9%
0.00%
Q3 2020$1,424,000
-18.4%
596,125
+0.1%
0.00%
-100.0%
Q2 2020$1,745,000
+22.6%
595,525
+20.5%
0.00%0.0%
Q1 2020$1,423,000
+1.1%
494,174
+40.5%
0.00%
Q4 2019$1,407,000
+149.5%
351,795
+177.7%
0.00%
Q3 2019$564,000
+652.0%
126,669
+553.3%
0.00%
Q2 2019$75,000
-7.4%
19,389
-9.2%
0.00%
Q1 2019$81,000
-60.3%
21,344
-34.9%
0.00%
Q3 2018$204,000
-52.4%
32,807
-64.8%
0.00%
Q1 2018$429,000
+337.8%
93,294
+205.7%
0.00%
Q4 2017$98,000
-8.4%
30,520
+130.5%
0.00%
Q4 2015$107,000
-6.1%
13,243
-2.9%
0.00%
Q3 2015$114,000
-5.0%
13,635
+5.4%
0.00%
Q2 2015$120,000
-20.5%
12,937
-16.0%
0.00%
Q1 2015$151,00015,4000.00%
Other shareholders
ADMA BIOLOGICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Velan Capital Investment Management LP 4,000,000$15,520,00013.71%
Stonepine Capital Management, LLC 6,940,000$26,927,20011.33%
Caligan Partners LP 2,676,093$10,383,2418.64%
Altium Capital Management LP 2,870,000$11,135,6005.66%
AWM Investment Company, Inc. 6,015,000$23,338,2003.36%
EAM Investors, LLC 1,749,598$6,788,4401.40%
Perceptive Advisors 11,900,255$46,172,9891.30%
EAM Global Investors LLC 836,323$3,244,9330.84%
Potomac Capital Management, Inc. 120,000$4660.54%
OBERWEIS ASSET MANAGEMENT INC/ 536,900$2,083,1720.44%
View complete list of ADMA BIOLOGICS INC shareholders